Clinical Trials Insight: 700023576
Phase of Trial: Phase II
Latest Information Update: 18 May 2010
At a glance
- Drugs Taberminogene vadenovec (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- Sponsors Ark Therapeutics
- 18 May 2010 Following a strategic review, work has begun to modify the existing Trinam phase III trial to a phase IIb trial according to an Ark Therapeutics media release.
- 18 May 2010 Recruitment into the revised trial is being driven hard and the results from the trial are expected in mid-2011 according to an Ark Therapeutics media release.
- 16 May 2008 This trial is expected to begin by mid 2008.